12.05.2016 • News • Christian Kullmann • Evonik • Klaus Engel

Kullmann appointed Deputy Chairman of the Executive Board of Evonik

The Supervisory Board of Evonik appointed Christian Kullmann (47) Deputy Chairman of the Executive Board with immediate effect. Kullmann has been on the Executive Board since July 2014 and has the role of chief strategic officer. He joined the company in 2003.

Klaus Engel, Chairman of the Executive Board, compliments Kullmann, who could become his designated successor: “I highly recommended Christian Kullmann as a Board Member at the time, and I now recommend him equally highly as my deputy. He stands for continuity and dependability towards employees, customers and investors. We will continue along our successful path in the same spirit of trusting cooperation.”

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.